Infection Control Market Size, Share, Industry Trends and Forecast 2026-2034

According to IMARC Group, the global Infection Control Market Size reached USD 29.9 Billion in 2025 and is projected to expand to USD 51.1 Billion by 2034, growing at a CAGR of 5.97% during 2026–2034. This robust Infection Control Market Growth reflects heightened awareness of hygiene standards, rapid advances in sterilization and disinfection technologies, surging geriatric populations, and the mounting global burden of HAIs driving demand across healthcare settings worldwide.

Infection Control Market Overview

Infection control encompasses the policies, procedures, technologies, and products deployed to prevent the transmission of infectious agents in healthcare and related settings. It spans three major categories: equipment (disinfectors and sterilization systems), services (contract sterilization and infectious waste disposal), and consumables (disinfectants, sterilization consumables, and personal protective equipment).

The infection control landscape is shaped by stringent regulatory frameworks, evolving pathogen profiles, advancing disinfection technologies, and the structural expansion of global healthcare infrastructure. Infection Control Market Analysis reveals that the sector is evolving rapidly moving from manual, labor-intensive approaches toward automated, digitally traceable, and AI-assisted sterilization and hygiene systems.

Key infection control product and service categories include:

• Sterilization equipment: heat, low-temperature, radiation, and filtration-based systems

• Disinfectors: washers, flushers, and ultrasonic cleaners

• Contract sterilization services: ETO, gamma, e-beam, and steam sterilization

• Consumables: surface disinfectants, PPE, autoclave bags, and indicator tapes

• Infectious waste disposal services

Global Infection Control Market Size & Key Statistics

Below are the key Infection Control Market statistics drawn from IMARC Group's comprehensive market analysis:

Base Year - 2025

Historical Period - 2020–2025

Forecast Period - 2026–2034

Infection Control Market Size in 2025 - USD 29.9 Billion

Market Forecast in 2034 - USD 51.1 Billion

Market Growth Rate (2026–2034) - 5.97% CAGR

Largest Region - North America

Leading Type Segment - Consumables

Leading End-User Segment - Hospitals and Clinics

Key Market Drivers & Infection Control Market Trends in 2026

Several powerful forces are shaping Infection Control Market Trends and fuelling sustained growth across global healthcare markets:

1. Growing Aging Population

The global geriatric population is rising substantially, with the WHO projecting that one in six people worldwide will be aged 60 or above by 2030 representing approximately 1.4 billion individuals. By 2050, this figure is expected to reach 2.1 billion. Older individuals commonly exhibit weaker immune responses and greater vulnerability to infections, driving consistent demand for rigorous infection control measures in hospitals, nursing homes, and long-term care facilities as a core Infection Control Market Trend.

2. Rising Prevalence of Healthcare-Associated Infections (HAIs)

The growing frequency of HAIs including surgical site infections, catheter-related infections, and ventilator-associated pneumonia represents a significant clinical and financial burden. The European Centre for Disease Prevention and Control reports that nearly 4.3 million hospital patients in the EU/EEA acquire at least one HAI each year. This alarming statistic is directly accelerating investment in advanced disinfection and sterilization technologies across healthcare institutions globally.

3. Expanding Ambulatory Services Sector

The rapid shift toward outpatient care is a major driver of infection control product demand. The worldwide ambulatory services market reached USD 3.8 Trillion in 2023 and is projected to expand to USD 6.3 Trillion by 2032 at a 5.7% CAGR. High patient turnover, swift treatment cycles, and the necessity to avert cross-contamination are making dependable sterilization, surface disinfection, and PPE solutions essential across outpatient settings — broadening the infection control addressable market significantly.

4. Technological Advancement and Product Innovation

Innovations in disinfection and sterilization are transforming clinical workflows. Automated sterilization systems, intelligent monitoring platforms, advanced chemical formulations, and real-time traceability tools are enhancing reliability and reducing human error. A notable example is Getinge's Poladus 150 launched in 2024 — a low-temperature VH₂O₂ sterilizer with cross-contamination prevention technology and digital platform integration, offering improved traceability and operational effectiveness in hospital sterile supply units.

5. Public Health Campaigns and Government Initiatives

Government-led public health initiatives are vital catalysts for the Infection Control Market. National healthcare strategies increasingly prioritize infection prevention as a core goal. Programmes promoting hand hygiene, responsible antimicrobial use, and adherence to clinical best practices are generating consistent demand for standardized consumables, disinfectants, and sterilization devices — particularly in developing regions where awareness and infrastructure are still maturing.

6. Industry Collaboration and Strategic Partnerships

Collaborations between medical device manufacturers and healthcare stakeholders are expanding access to advanced technologies and promoting infection prevention education. The joint initiative by Bactiguard and BD at CRITICARE 2025 in India — highlighting catheter-associated urinary tract infection (CAUTI) prevention and antimicrobial resistance management — exemplifies how industry partnerships are deepening clinical adoption of infection control innovations in high-need markets.

7. Increasing Focus on Surgical Volume and Sterile Environments

The rise in elective and emergency surgical procedures is driving demand for sterile environments and comprehensive infection control protocols. Surgical suites require rigorous sterilization covering a wide range of supplies and instruments. With global surgical volumes on the rise, consistent infection control is an expanding area of focus and investment for healthcare institutions worldwide.

Key Infection Control Market Segmentation

By Type

Consumables – Largest Segment: Consumables account for the largest market share, encompassing disinfectants, sterilization consumables (autoclave bags, indicator tapes), and personal protective equipment. Their disposable characteristics ensure hygiene, minimize contamination risks, and support regulatory compliance. Every clinical procedure consumes recurring volumes of consumables, creating a revenue base that scales proportionally with healthcare activity levels globally.

Equipment: The equipment segment includes disinfectors (washers, flushers, ultrasonic cleaners) and sterilization equipment (heat, low-temperature, radiation, and filtration-based systems). The capital-equipment layer is being transformed by automation, smart monitoring, and digital traceability integrations — driving replacement cycles and greenfield installations across expanding healthcare infrastructure.

Services: Contract sterilization services — ETO, gamma, e-beam, and steam sterilization — alongside infectious waste disposal represent the services segment, capturing outsourced sterilization volume from healthcare facilities, pharmaceutical manufacturers, and medical device companies seeking reliable, validated third-party processing.

By End User

Hospitals and Clinics – Largest Segment: Hospitals and clinics dominate the end-user segment due to their high patient turnover, complex multi-departmental procedures, and stringent cleanliness standards. These settings are high-risk environments where infection prevention is paramount to patient safety, regulatory compliance, and hospital accreditation — sustaining robust and consistent demand for infection control solutions.

Medical Device Companies: Medical device manufacturers integrate infection control into their sterilization and reprocessing workflows, representing a significant end-user segment requiring validated sterility assurance across production and post-market activities.

Clinical Laboratories: Laboratories require rigorous surface disinfection, PPE, and biological waste management protocols to prevent cross-contamination and ensure accurate diagnostic results.

Pharmaceutical Companies: Pharmaceutical manufacturing demands clean-room grade infection control across sterile manufacturing facilities, driving demand for high-grade sterilization equipment and validated consumables.

Regional Infection Control Market Analysis

North America – Largest

United States & Canada; robust healthcare infrastructure, significant aging population, strict HAI regulatory enforcement, advanced adoption of automated sterilization and disinfection technologies

Europe

Germany, France, UK, Italy, Spain, Russia; ECDC HAI frameworks, IVDR compliance, active government infection prevention programmes, strong manufacturing base (Getinge, Belimed)

Asia-Pacific

China, Japan, India, South Korea, Australia, Indonesia; fastest-growing region, expanding hospital infrastructure, rising surgical volumes, government healthcare modernization initiatives

Latin America

Brazil, Mexico; Brazil largest LatAm healthcare market, growing HAI awareness, expanding private hospital sector driving adoption

Middle East & Africa

UAE, Saudi Arabia, South Africa; Saudi Vision 2030, healthcare modernization, rising chronic disease burden, growing focus on clinical hygiene standards

According to Infection Control Market Analysis, North America dominates the global market owing to its advanced healthcare infrastructure, significant aging population, and strict enforcement of infection control standards. The US aging population — projected to rise from 58 million in 2022 to 82 million by 2050 — structurally sustains demand for rigorous infection prevention in hospitals and long-term care settings.

Leading Players in the Infection Control Industry

The global infection control market features diversified healthcare conglomerates alongside focused infection prevention specialists. Key companies covered in the IMARC Group report include:

• 3M Company
• Advanced Sterlization Products Services Inc. (Fortive Corporation)
• Belimed AG (Metall Zug)
• Cantel Medical Corp.
• Getinge AB
• Matachana
• Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.)
• MMM Münchener Medizin Mechanik GmbH
• Pal International
• Sterigenics U.S. LLC (Sotera Health Holdings LLC)
• Steris Corporation
• TSO3 Inc. (Stryker Corporation)

The report includes competitive analysis covering market structure, player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant.

About Us

IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Healthcare, Technology, Chemicals, Energy, Food & Beverages, and more.

Contact Us

IMARC Group

United States: +1-201-971-6302

India: +91-120-433-0800

United Kingdom: +44-753-714-6104

Article source: https://article-realm.com/article/Health-Fitness/84388-Infection-Control-Market-Size-Share-Industry-Trends-and-Forecast-2026-2034.html